MERCURO, GIUSEPPE
 Distribuzione geografica
Continente #
EU - Europa 342.248
NA - Nord America 17.226
AS - Asia 2.723
AF - Africa 888
OC - Oceania 63
SA - Sud America 33
Continente sconosciuto - Info sul continente non disponibili 7
Totale 363.188
Nazione #
IT - Italia 338.202
US - Stati Uniti d'America 17.105
CN - Cina 1.606
UA - Ucraina 1.443
SE - Svezia 1.015
ZA - Sudafrica 721
GB - Regno Unito 457
FI - Finlandia 387
SG - Singapore 385
DE - Germania 364
IN - India 223
FR - Francia 124
VN - Vietnam 108
BD - Bangladesh 99
CA - Canada 96
BE - Belgio 66
KE - Kenya 53
NL - Olanda 37
KR - Corea 36
RU - Federazione Russa 33
SA - Arabia Saudita 33
AU - Australia 31
ZM - Zambia 29
TR - Turchia 28
PK - Pakistan 27
PH - Filippine 22
UG - Uganda 21
ES - Italia 20
IR - Iran 20
BR - Brasile 19
ID - Indonesia 19
NP - Nepal 17
PL - Polonia 15
MY - Malesia 14
GR - Grecia 13
NG - Nigeria 13
FJ - Figi 12
HK - Hong Kong 12
AE - Emirati Arabi Uniti 11
JP - Giappone 11
NZ - Nuova Zelanda 11
GH - Ghana 10
IE - Irlanda 10
CO - Colombia 9
MW - Malawi 9
RO - Romania 9
TW - Taiwan 8
AT - Austria 7
EU - Europa 7
IL - Israele 7
PT - Portogallo 7
TH - Thailandia 7
TZ - Tanzania 7
ZW - Zimbabwe 7
LK - Sri Lanka 6
RS - Serbia 6
BG - Bulgaria 5
CH - Svizzera 5
LC - Santa Lucia 5
MU - Mauritius 5
PG - Papua Nuova Guinea 5
PR - Porto Rico 5
CY - Cipro 4
KH - Cambogia 4
KW - Kuwait 4
NO - Norvegia 4
SB - Salomone, isole 4
SI - Slovenia 4
CL - Cile 3
LS - Lesotho 3
LT - Lituania 3
MX - Messico 3
TT - Trinidad e Tobago 3
CI - Costa d'Avorio 2
CU - Cuba 2
DK - Danimarca 2
IQ - Iraq 2
JM - Giamaica 2
LU - Lussemburgo 2
MM - Myanmar 2
MT - Malta 2
MZ - Mozambico 2
OM - Oman 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SZ - Regno dello Swaziland 2
AM - Armenia 1
AR - Argentina 1
BW - Botswana 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DM - Dominica 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GD - Grenada 1
GP - Guadalupe 1
HR - Croazia 1
JO - Giordania 1
KZ - Kazakistan 1
Totale 363.183
Città #
Cagliari 327.556
Uta 9.770
Fairfield 2.496
Woodbridge 1.745
Houston 1.358
Chandler 1.285
Ashburn 1.190
Ann Arbor 1.136
Wilmington 1.020
Seattle 948
Boardman 923
Cambridge 891
Nyköping 793
Jacksonville 768
Dearborn 456
Nanjing 287
Beijing 253
Boston 228
Johannesburg 176
Helsinki 173
Singapore 173
Shanghai 163
San Diego 151
Dong Ket 104
Shenyang 98
New York 90
Redwood City 89
Nanchang 87
Milan 81
Hebei 80
Guangzhou 79
Jiaxing 70
Cape Town 65
Toronto 65
Pretoria 63
Changsha 61
London 55
Tianjin 52
Norwalk 48
Mountain View 45
Los Angeles 42
Brussels 40
Orange 38
Atlanta 37
Jinan 37
Verona 34
Auburn Hills 31
Hefei 30
Washington 30
Lusaka 29
Durban 26
Seoul 26
Sassari 25
Nairobi 24
Wuhan 24
Kunming 23
Ningbo 23
Zhengzhou 23
Falls Church 22
Pune 22
Amsterdam 17
Borås 17
Phoenix 17
Chicago 16
Dhaka 16
San Mateo 16
Augusta 15
Mumbai 13
Detroit 12
Redmond 12
Ankara 11
Kampala 11
Millbury 11
Rome 11
Taizhou 11
Torino 11
Hounslow 10
Saint Petersburg 10
Accra 9
Boksburg 9
Monmouth Junction 9
Sestu 9
Suva 9
Genova 8
Guwahati 8
Hangzhou 8
Bielefeld 7
Dar es Salaam 7
Davao 7
Dublin 7
Indiana 7
Indore 7
Jinhua 7
Kilburn 7
Kuala Lumpur 7
Leawood 7
Lilongwe 7
Munich 7
New Bedfont 7
Port Elizabeth 7
Totale 356.161
Nome #
Early ischemia identification employing 2D speckle tracking selective layers analysis during dobutamine stress echocardiography 4.243
Metabolomic approach to profile functional and metabolic changes in heart failure 4.083
Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy 4.033
Distinctive metabolomic fingerprint in scleroderma patients with pulmonary arterial hypertension 3.748
Endodontic infection and endothelial dysfunction are associated with different mechanisms in men and women 3.700
Timing of the negative effects of trastuzumab on cardiac mechanics after anthracycline chemotherapy 3.423
Blood metabolomic fingerprint is distinct in healthy coronary and in stenosing or microvascular ischemic heart disease 3.355
Contractile reserve in systemic sclerosis patients as a major predictor of global cardiac impairment and exercise tolerance 3.311
Effects of an adapted physical training on functional status, body composition and quality of life in persons with spinal cord injury paraplegia: a pilot study 3.297
Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 3.289
Effects of metformin and exercise training, alone or in combination, on cardiac function in individuals with insulin resistance 3.189
Metabolomics Profile of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 3.142
Epicardial fat thickness, an emerging cardiometabolic risk factor, is increased in young adults born preterm 2.995
A new type of physical activity from an ancient tradition: the Sardinian folk dance "ballu sardu" 2.971
Metabolomic fingerprint of coronary blood in STEMI patients depends on the ischemic time and inflammatory state 2.958
Effects of a mini-trampoline rebounding exercise program on functional parameters, body composition and quality of life in overweight women 2.905
A case of SAPHO syndrome with endodontic implications and treatment with biologic drugs 2.895
Metaboreflex-mediated hemodynamic abnormalities in individuals with coronary artery disease without overt signs or symptoms of heart failure 2.869
Metabolomics and heart failure: a new and promising scientific approach 2.841
Metabolomics and Cardiology: Toward the Path of Perinatal Programming and Personalized Medicine 2.829
Cardiovascular effects, body composition, quality of life and pain after a Zumba® fitness program in Italian overweight women 2.795
Coronary Artery Disease 2.777
Nitrergic system and plasmatic methylarginines: Evidence of their role in the perinatal programming of cardiovascular diseases 2.739
Altered transmural contractility in postmenopausal women affected by cardiac syndrome X 2.696
Long-term Protective Effects of the Angiotensin Receptor Blocker Telmisartan on Epirubicin-induced Inflammation, Oxidative Stress and Myocardial Dysfunction 2.684
Effects of a nordic walking program on motor and non-motor symptoms, functional performance and body composition in patients with Parkinson's disease 2.643
Modelling chemotherapy-induced cardiotoxicity by human pluripotent stem cells 2.612
Cardioprotection by gene therapy: review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology 2.597
Pharmacological treatment of vagal hyperactivity, a rare but potentially fatal cause of sudden cardiac death 2.596
Sardinian Folk Dance for Individuals with Parkinson's Disease: A Randomized Controlled Pilot Trial 2.580
Fully-textile polymer-based ECG electrodes: overcoming the limits of metal-based textiles 2.562
Metabolomics, a promising approach to translational research in cardiology 2.548
Metabolomic approach to redox and nitrosative reactions in cardiovascular diseases 2.529
Premature vascular deterioration in young patients affected by Wilson's disease: a pilot study 2.381
Zumba Fitness and Women’s Cardiovascular Health: A SYSTEMATIC REVIEW 2.372
Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection 2.370
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 2.351
Sex-related differential susceptibility to ponatinib cardiotoxicity and differential modulation of the Notch1 signalling pathway in a murine model 2.320
Aquatic exercise improves motor impairments in people with Parkinson's disease, with similar or greater benefits than land-based exercise: a systematic review 2.312
Impaired endothelial function in hereditary angioedema during the symptom-free period 2.267
Effects of Metformin Treatment on Myocardial and Endothelial Function in Insulin Resistance Patients: A Metabolomic Study. 2.263
Effects of an adapted physical activity program on motor and non-motor functions and quality of life in patients with Parkinson's disease 2.241
Antioxidant approach as a cardioprotective strategy in chemotherapy-induced cardiotoxicity 2.222
null 2.211
null 2.190
Muscle MRI findings in patients with an apparently exclusive cardiac phenotype due to a novel LMNA gene mutation 2.187
A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology 2.185
The perioperative dental screening and management of patients undergoing cardiothoracic, vascular surgery and other cardiovascular invasive procedures: A systematic review 2.164
Study of autonomic cardiovascular dysfunction in Parkinson’s disease patients with LRRK2 mutations using Heart Rate Variability 2.127
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 2.120
Impaired central arterial elasticity in young adults born with intrauterine growth restriction 2.076
Perioperative dental screening and treatment in patients undergoing cardio-thoracic surgery and interventional cardiovascular procedures. A consensus report based on RAND/UCLA methodology. 2.038
Ponatinib Induces Vascular Toxicity through the Notch-1 Signaling Pathway 2.028
Effects of an aquatic-based exercise program to improve cardiometabolic profile, quality of life, and physical activity levels in men with type 2 diabetes mellitus 2.026
Reply to comment on: “Nordic Walking for the Management of People with Parkinson Disease: A Systematic Review” 2.024
Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 2.015
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world 2.013
Autonomic imbalance in Parkinson's disease patients with or without LRRK2 gene mutations 2.012
Study on the correlation among total burden of nonmotor symptoms and cardiovascular dysmodulation in Parkinson’s disease patients 1.996
Inverted Takotsubo cardiomyopathy induced by dobutamine stress echocardiography with atypical presentation 1.992
Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations 1.981
Antineoplastic drug-induced cardiotoxicity: A redox perspective 1.965
Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects 1.961
Trastuzumab-based adjuvant chemotherapy for breast cancer: Early myocardial dysfunction detected by "speckle tracking" echocardiography (STE). 1.961
Antihypertensive therapy in children: differences in medical approach between the United States and Europe 1.960
The need of a gender-corrected evidence based medicine 1.947
IGENDA protocol: gender differences in awareness, knowledge and perception of cardiovascular risk: an Italian multicenter study 1.944
Abnormal atrial activation at surface electrocardiogram examination in born underweight young adults 1.939
Clinical metabolomics and hematic ADMA predict the future onset of cardiorenal syndrome in young grown-up subjects who were born preterm 1.902
Supervised aquatic-based exercise for men with coronary artery disease: a meta-analysis of randomised controlled trials 1.876
Could ADMA levels in young adults born preterm predict an early endothelial dysfunction? 1.857
Altered aortic upper wall TDI velocity is inversely related with left ventricular diastolic function in operated tetralogy of Fallot 1.855
Apical periodontitis and cardiovascular diseases: previous findings and ongoing research 1.851
An old drug for use in the prevention of sudden infant unexpected death due to vagal hypertonia 1.827
Metabolic pathways in heart failure correlate with impaired longitudinal global strain rate 1.826
Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogens 1.824
Association of endodontic infection with detection of an initial lesion to the cardiovascular system 1.823
Chemotherapy-induced cardiotoxicity: new insights into mechanisms, monitoring, and prevention 1.818
Current views on anthracycline cardiotoxicity 1.782
Arterial hypertension in the female world: Pathophysiology and therapy 1.779
Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry 1.763
Ultrasound examination for the detection of simulated periapical bone lesions in bovine mandibles: an ex vivo study 1.763
Diabetic cardiomyopathy and ischemic heart disease: Prevention and therapy by exercise and conditioning 1.733
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 1.694
Early right ventricular dysfunction in highly selected (totally free from cardiovascular risk factors and other comorbidities) human immunodeficiency virus patients: A pilot study with advanced echocardiography 1.677
Effects of metformin and exercise training, alone or in association, on cardio-pulmonary performance and quality of life in insulin resistance patients 1.674
Multimodality imaging diagnosis of multiple ventricular thrombosis and massive stroke after gemcitabine and cisplatin chemotherapy for Urothelial Cancer 1.670
Bridging the mortality gap: A new challenge in percutaneous coronary intervention for patients with cancer 1.654
Gender differences in cardiology: is it time for new guidelines? 1.644
Preventing antiblastic drug-related cardiomyopathy: Old and new therapeutic strategies 1.629
null 1.595
A systematic overview to quantify the gender imbalance in cardiovascular rehabilitation trials 1.594
A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: An opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology 1.581
L’analisi metabolomica delle vie metaboliche nei pazienti affetti da scompenso cardiaco correla con lo strain rate longitudinale 1.573
Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.563
Metabolomic perspectives in antiblastic cardiotoxicity and cardioprotection 1.563
Cardiovascular prevention in women: A narrative review from the Italian Society of Cardiology working groups on 'Cardiovascular Prevention, Hypertension and peripheral circulation' and on 'Women Disease' 1.525
Early diagnosis, clinical management, and follow-up of cardiovascular events with ponatinib 1.507
Atrial fibrillation in a preterm newborn with structurally normal heart 1.494
null 1.489
Totale 229.000
Categoria #
all - tutte 446.535
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 446.535


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202055.899 0 0 0 1.183 22.024 15.418 8.658 2.044 1.264 1.416 1.459 2.433
2020/202185.933 2.619 3.485 3.333 21.907 17.474 9.937 6.930 5.608 2.372 4.709 4.333 3.226
2021/202218.526 2.175 1.204 956 1.607 1.395 1.332 989 1.155 1.895 1.689 1.954 2.175
2022/202326.476 2.651 3.900 3.513 2.267 2.246 2.258 1.128 2.121 1.730 1.465 2.036 1.161
2023/202430.950 1.668 1.166 1.376 2.261 3.046 4.843 4.853 2.585 1.707 2.135 2.774 2.536
2024/202538.221 10.698 13.807 10.648 3.068 0 0 0 0 0 0 0 0
Totale 364.202